| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |